Message from the Chairman

Accumulation of knowledge from basic research is indispensable for revealing the true cause of a disease and for developing effective medical treatment methods. To this extent, in vivo experiments using animals become a necessary process prior to the treatment and drug prescription on human beings.

Founded in 1952, the Central Institute for Experimental Animals (CIEA) has continued contributing to the health and welfare of humankind through the provision of quality laboratory animals with a high reproducible level, together with the establishment of sophisticated test method systems.

The first 40 years of the CIEA’s creation focused on building the technological infrastructures required for developing new drugs and medical treatments. The following 20 years has been spent exploring various application methods of the results of basic research, together with the development of the most advanced technologies related to the medical arena. For example, genetically modified Common Marmosets that the CIEA successfully created for the first time in the world are perceived as very promising practical model animals for exploiting a completely new path in treating intractable diseases that have so far been considered incurable.

In the summer of 2011, the CIEA was opened new facilities in the coastal area of Kawasaki City. The facilities are adjacent to the new Haneda International Airport that is anticipated to become Japan’s aerial hub in the years to come. In order to contribute further to those seeking new treatments and drugs, the new facilities will collaborate with many in the fields of pharmaceuticals, medical-related industries, foodstuffs and venture businesses. The CIEA pursues to create various innovative industrial foundation skills that contribute to reinforce the competitive power of Japan, which ultimately serve for the betterment of all human beings living on this globe.

Thank you very much for your continued support of the CIEA.